Indication

Eczema

Eczema is a broad term encompassing chronic, relapsing inflammatory dermatoses of the integumentary system, most commonly referring to atopic dermatitis. Read more about Eczema

0 drugs 0 manufacturers

Advertisement

Drugs that treat it

Common Eczema therapies.

0 drugs

No drugs are available

This indication does not currently contain public drugs.

Filter & compare in the drug finder →Opens the drug finder with Eczema preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Eczema.

Eczema is a broad term encompassing chronic, relapsing inflammatory dermatoses of the integumentary system, most commonly referring to atopic dermatitis.

It affects populations across all ages, presenting most frequently in early childhood and often persisting into or manifesting in adulthood.

Pathophysiologically, the condition is driven by epidermal barrier disruption, heightened transepidermal water loss, immune dysregulation predominantly mediated by type 2 cytokine signaling, and cutaneous neurosensory hyperactivity.

Clinically, it is characterized by xerosis, intense pruritus, and localized erythematous macules or plaques that can progress to weeping, excoriation, and lichenification.

Personalize your experience

Follow Eczema and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it